A Practical Review of C-Peptide Testing in Diabetes

Inpatient Glycemic Variability and Long-Term Mortality in Hospitalized Patients with Type 2 Diabetes

(2017) Joseph G. Timmons et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c

(2016) Xixiang Tang et al.   CLINICA CHIMICA ACTA

Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up

(2016)   DIABETES CARE

Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic

(2016) S. V. Hope et al.   DIABETIC MEDICINE

Aims and Scope

(2016)   DIABETIC MEDICINE

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS

(2016) Yehuda Handelsman et al.   Endocrine Practice

C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy

(2016) Sevin Demir et al.   Journal of Diabetes Research

C-peptide as a risk factor of coronary artery disease in the general population

(2015) Antonio Cabrera de León et al.   Diabetes & Vascular Disease Research

Low levels of C-peptide have clinical significance for established Type 1 diabetes

(2015) W. M. Kuhtreiber et al.   DIABETIC MEDICINE

Importance of adherance to yoga in management of type 2 diabetes

(2015) Gaurav Kumar et al.   International Journal of Diabetes in Developing Countries

Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature

(2015) Beverley M Shields et al.   BMJ Open

Physiological effects and therapeutic potential of proinsulin C-peptide

(2014) Gina L. C. Yosten et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Glycemic Variability in Patients With Early Type 2 Diabetes: The Impact of Improvement in β-Cell Function

(2014) Caroline K. Kramer et al.   DIABETES CARE

Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes

(2014) Asa K. Davis et al.   DIABETES CARE

C-peptide concentration, mortality and vascular complications in people with Type 2 diabetes. The Skaraborg Diabetes Register

(2014) M. Pikkemaat et al.   DIABETIC MEDICINE

Serum C-peptide levels and risk of death among adults without diabetes mellitus

(2013) J.-y. Min et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

(2013) J. M. Lachin et al.   DIABETES

The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study

(2013) K. Y. Thong et al.   DIABETIC MEDICINE

Urinary C-peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes

(2013) S. V. Hope et al.   DIABETIC MEDICINE

The clinical utility of C-peptide measurement in the care of patients with diabetes

(2013) A. G. Jones et al.   DIABETIC MEDICINE

Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes

(2013) Tae Jung Oh et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes

(2013) Yoko Okuno et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fasting Serum C‐Peptide Levels Predict Cardiovascular and Overall Death in Nondiabetic Adults

(2013) Nileshkumar Patel et al.   Journal of the American Heart Association

C-Peptide Prevents Hyperglycemia-Induced Endothelial Apoptosis Through Inhibition of Reactive Oxygen Species–Mediated Transglutaminase 2 Activation

(2012) Mahendra Prasad Bhatt et al.   DIABETES

Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data

(2012) C. J. Greenbaum et al.   DIABETES

C-Peptide Levels Are Associated With Mortality and Cardiovascular Mortality in Patients Undergoing Angiography: The LURIC study

(2012) N. Marx et al.   DIABETES CARE

Persistence of Prolonged C-peptide Production in Type 1 Diabetes as Measured With an Ultrasensitive C-peptide Assay

(2012) L. Wang et al.   DIABETES CARE

C-peptide response to glucagon challenge is correlated with improvement of early insulin secretion by liraglutide treatment

(2012) Michinori Takabe et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes

(2012) B. M. Shields et al.   DIABETOLOGIA

EDTA Improves Stability of Whole Blood C-Peptide and Insulin to Over 24 Hours at Room Temperature

(2012) Timothy J. McDonald et al.   PLoS One

The impact of gender on urine C-peptide creatinine ratio interpretation

(2012) N. J. Thomas et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Position Statement Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus

(2011) D. B. Sacks et al.   DIABETES CARE

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1- /Hepatocyte Nuclear Factor 4-  Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes

(2011) R. E. J. Besser et al.   DIABETES CARE

Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes

(2011) P. Bowman et al.   DIABETIC MEDICINE

C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells

(2011) V. Cifarelli et al.   DIABETOLOGIA

Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus

(2011) Soon Ae Kim et al.   Diabetes & Metabolism Journal

Stability and Reproducibility of a Single-Sample Urinary C-Peptide/Creatinine Ratio and Its Correlation with 24-h Urinary C-Peptide

(2009) T. J. McDonald et al.   CLINICAL CHEMISTRY

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of  -Cell Function in Therapeutic Trials in Type 1 Diabetes

(2008) C. J. Greenbaum et al.   DIABETES CARE

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial

(2008) E. S. Kilpatrick et al.   DIABETES CARE